A Workflow Combining Machine Learning with Molecular Simulations Uncovers Potential Dual-Target Inhibitors against BTK and JAK3

The drug development process suffers from low success rates and requires expensive and time-consuming procedures. The traditional one drug–one target paradigm is often inadequate to treat multifactorial diseases. Multitarget drugs may potentially address problems such as adverse reactions to drugs....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lu, Na, Risong, Yang, Lianjuan, Liu, Jixiang, Tan, Yingjia, Zhao, Xi, Huang, Xuri, Chen, Xuecheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608827/
https://www.ncbi.nlm.nih.gov/pubmed/37894618
http://dx.doi.org/10.3390/molecules28207140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608827/
https://www.ncbi.nlm.nih.gov/pubmed/37894618
http://dx.doi.org/10.3390/molecules28207140

Ejemplares similares